Sort
48,018 grants matching “immunotherapy”
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,250,220David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
SPORE: Targeted Therapies for Glioma
$2,250,039Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2022 · CA
Georgetown University Lombardi Cancer Center Support Grant
$2,250,000Louis M Weiner · Georgetown University · P30 · FY2014 · CA
Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT)
$2,250,000Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2025 · AI
Controlling and Preventing Asthma Progression and Severity in Kids with Omalizumab Extension (PARK-EXT)
$2,250,000Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2024 · AI
Engineering Tregs for autoimmune diabetes therapy
$2,249,376Brian T Fife · University Of Minnesota · R01 · FY2025 · DK
Stanford University Cancer Center
$2,249,153Beverly Shriver Mitchell · Stanford University · P30 · FY2015 · CA
GENERAL CLINICAL RESEARCH CENTER
$2,247,575Scripps Research Institute · M01 · FY2000 · RR
Georgetown University Lombardi Cancer Center Support Grant
$2,246,754Louis M Weiner · Georgetown University · P30 · FY2015 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,245,745Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,245,572Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,243,861Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2024 · AG
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,243,520James Brugarolas · Ut Southwestern Medical Center · P50 · FY2024 · CA
Cancer as a Complex Adaptive System
$2,240,338Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2017 · CA
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,238,755Northwestern University · U01 · FY2003 · AI
Next generation T cell therapies for mutant KRAS solid tumors
$2,238,704Beatriz M. Carreno · University Of Pennsylvania · UH3 · FY2025 · CA
Gene therapy of cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Gene-engineered adoptive T cell immunotherapy of GBM
$2,237,545Laura A Johnson · University Of Pennsylvania · DP2 · FY2012 · CA
The Johns Hopkins University - Uganda Clinical Trials Unit
$2,237,197Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2021 · AI
Immunotherapeutic Modulation of Peanut Allergy
$2,236,829Robert A Wood · Icahn School Of Medicine At Mount Sinai · U19 · FY2013 · AI
Lymphoma Specialized Program of Research Excellence
$2,236,116University Of Iowa · P50 · FY2002 · CA
Mayo Clinic Hepatobiliary SPORE
$2,236,005Mark A. Mc Niven · Mayo Clinic Rochester · P50 · FY2024 · CA
On-Chip Multiplexed Adhesion Frequency Assay for Measuring Receptor-Ligand Interactions on Cells
$2,235,836Yuebing Zheng · University Of Texas At Austin · DP2 · FY2017 · GM
MD Anderson Cancer Center Prostate Cancer SPORE
$2,235,720Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA